Cargando…
Sex Differences in the Effects of a Biological Drug for Rheumatoid Arthritis on Depressive State
OBJECTIVE : Sex-specific medicine has attracted attention in recent years, but no report on rheumatoid arthritis (RA) has examined sex differences in the effectiveness of biologics on activities of daily living (ADL), quality of life (QOL), or depressive state. METHODS : The study subjects were 161...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541463/ https://www.ncbi.nlm.nih.gov/pubmed/26312106 http://dx.doi.org/10.2174/1874312901409010051 |
_version_ | 1782386390909059072 |
---|---|
author | Tokunaga, Takahiro Miwa, Yusuke Nishimi, Airi Nishimi, Shinichiro Saito, Mayu Oguro, Nao Miura, Yoko Ishii, Sho Takahashi, Ryo Kasama, Tsuyoshi Sanada, Kenji |
author_facet | Tokunaga, Takahiro Miwa, Yusuke Nishimi, Airi Nishimi, Shinichiro Saito, Mayu Oguro, Nao Miura, Yoko Ishii, Sho Takahashi, Ryo Kasama, Tsuyoshi Sanada, Kenji |
author_sort | Tokunaga, Takahiro |
collection | PubMed |
description | OBJECTIVE : Sex-specific medicine has attracted attention in recent years, but no report on rheumatoid arthritis (RA) has examined sex differences in the effectiveness of biologics on activities of daily living (ADL), quality of life (QOL), or depressive state. METHODS : The study subjects were 161 RA patients (female: 138; male: 23) attending regular doctor visits at our hospital. We compared the changes in disease activity, which was evaluated using the simplified disease activity index (SDAI), ADL (using the modified health assessment questionnaire; mHAQ), QOL (using short form-36; SF-36), and the Hamilton Depression Rating Scale (HAM-D) for RA patients between each sex over a six-month observation period while administering biologic treatment. RESULTS : The female patients reported significant improvements in the following metrics: SDAI: from 22.1 ± 11.9 to 8.9 ± 7.8 (p < 0.001); mHAQ: from 0.46 ± 0.50 to 0.32 ± 0.45 (p < 0.001); and HAM-D: from 6.2 ± 4.8 to 3.8 ± 4.1 (p < 0.001). Moreover, all eight items of the SF-36 were significantly improved (p < 0.01). In contrast, the male patients improved on the SDAI (from 27.9 ± 11.7 to 12.7 ± 8.6 (p < 0.001)), but we did not observe significant improvements in the mHAQ or HAM-D scores or in any items on the SF-36. CONCLUSION : Both male and female patients with RA improved when using a biological drug. Sex differences in the improvement of depressive state were observed. |
format | Online Article Text |
id | pubmed-4541463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Bentham Open |
record_format | MEDLINE/PubMed |
spelling | pubmed-45414632015-08-26 Sex Differences in the Effects of a Biological Drug for Rheumatoid Arthritis on Depressive State Tokunaga, Takahiro Miwa, Yusuke Nishimi, Airi Nishimi, Shinichiro Saito, Mayu Oguro, Nao Miura, Yoko Ishii, Sho Takahashi, Ryo Kasama, Tsuyoshi Sanada, Kenji Open Rheumatol J Article OBJECTIVE : Sex-specific medicine has attracted attention in recent years, but no report on rheumatoid arthritis (RA) has examined sex differences in the effectiveness of biologics on activities of daily living (ADL), quality of life (QOL), or depressive state. METHODS : The study subjects were 161 RA patients (female: 138; male: 23) attending regular doctor visits at our hospital. We compared the changes in disease activity, which was evaluated using the simplified disease activity index (SDAI), ADL (using the modified health assessment questionnaire; mHAQ), QOL (using short form-36; SF-36), and the Hamilton Depression Rating Scale (HAM-D) for RA patients between each sex over a six-month observation period while administering biologic treatment. RESULTS : The female patients reported significant improvements in the following metrics: SDAI: from 22.1 ± 11.9 to 8.9 ± 7.8 (p < 0.001); mHAQ: from 0.46 ± 0.50 to 0.32 ± 0.45 (p < 0.001); and HAM-D: from 6.2 ± 4.8 to 3.8 ± 4.1 (p < 0.001). Moreover, all eight items of the SF-36 were significantly improved (p < 0.01). In contrast, the male patients improved on the SDAI (from 27.9 ± 11.7 to 12.7 ± 8.6 (p < 0.001)), but we did not observe significant improvements in the mHAQ or HAM-D scores or in any items on the SF-36. CONCLUSION : Both male and female patients with RA improved when using a biological drug. Sex differences in the improvement of depressive state were observed. Bentham Open 2015-07-10 /pmc/articles/PMC4541463/ /pubmed/26312106 http://dx.doi.org/10.2174/1874312901409010051 Text en © Tokunaga et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Tokunaga, Takahiro Miwa, Yusuke Nishimi, Airi Nishimi, Shinichiro Saito, Mayu Oguro, Nao Miura, Yoko Ishii, Sho Takahashi, Ryo Kasama, Tsuyoshi Sanada, Kenji Sex Differences in the Effects of a Biological Drug for Rheumatoid Arthritis on Depressive State |
title | Sex Differences in the Effects of a Biological Drug for Rheumatoid Arthritis on Depressive State |
title_full | Sex Differences in the Effects of a Biological Drug for Rheumatoid Arthritis on Depressive State |
title_fullStr | Sex Differences in the Effects of a Biological Drug for Rheumatoid Arthritis on Depressive State |
title_full_unstemmed | Sex Differences in the Effects of a Biological Drug for Rheumatoid Arthritis on Depressive State |
title_short | Sex Differences in the Effects of a Biological Drug for Rheumatoid Arthritis on Depressive State |
title_sort | sex differences in the effects of a biological drug for rheumatoid arthritis on depressive state |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541463/ https://www.ncbi.nlm.nih.gov/pubmed/26312106 http://dx.doi.org/10.2174/1874312901409010051 |
work_keys_str_mv | AT tokunagatakahiro sexdifferencesintheeffectsofabiologicaldrugforrheumatoidarthritisondepressivestate AT miwayusuke sexdifferencesintheeffectsofabiologicaldrugforrheumatoidarthritisondepressivestate AT nishimiairi sexdifferencesintheeffectsofabiologicaldrugforrheumatoidarthritisondepressivestate AT nishimishinichiro sexdifferencesintheeffectsofabiologicaldrugforrheumatoidarthritisondepressivestate AT saitomayu sexdifferencesintheeffectsofabiologicaldrugforrheumatoidarthritisondepressivestate AT oguronao sexdifferencesintheeffectsofabiologicaldrugforrheumatoidarthritisondepressivestate AT miurayoko sexdifferencesintheeffectsofabiologicaldrugforrheumatoidarthritisondepressivestate AT ishiisho sexdifferencesintheeffectsofabiologicaldrugforrheumatoidarthritisondepressivestate AT takahashiryo sexdifferencesintheeffectsofabiologicaldrugforrheumatoidarthritisondepressivestate AT kasamatsuyoshi sexdifferencesintheeffectsofabiologicaldrugforrheumatoidarthritisondepressivestate AT sanadakenji sexdifferencesintheeffectsofabiologicaldrugforrheumatoidarthritisondepressivestate |